Similar results were obtained in another study of 90 pediatric B‐ALL cases, in which 56.7% of the cases had aberrant, higher CD86 expression on leukemic blasts compared to progenitor cells. The gene discussed is CD86; the disease is acute lymphoblastic leukemia.